XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Earnings Per Share
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
EARNINGS PER SHARE.

9. EARNINGS PER SHARE.

 

The following tables compute basic and diluted earnings per share (in thousands, except per share data):

 

   Three Months Ended
June 30, 2024		 
   Loss
Numerator		   Shares Denominator   Per-Share Amount 
Net loss  $(3,106)          
Less: Preferred stock dividends   (316)          
Basic and diluted loss per share:               
Loss available to common stockholders
  $(3,422)   73,486   $(0.05)

 

   Three Months Ended
June 30, 2023		 
   Income Numerator   Shares Denominator   Per-Share Amount 
Net income  $7,595           
Less: Preferred stock dividends   (315)          
Less: Income allocated to participating securities   (96)          
Basic income per share:               
Income available to common stockholders  $7,184    73,394   $0.10 
Add: Dilutive instruments   
—
    709      
Diluted income per share:               
Income available to common stockholders  $7,184    74,103   $0.10 

 

   Six Months Ended
June 30, 2024		 
   Loss
Numerator		   Shares Denominator   Per-Share Amount 
Net loss  $(14,831)          
Less: Preferred stock dividends   (631)          
Basic and diluted loss per share:               
Loss available to common stockholders
  $(15,462)   73,126   $(0.21)

 

   Six Months Ended
June 30, 2023		 
   Loss
Numerator		   Shares Denominator   Per-Share Amount 
Net loss  $(5,571)          
Less: Preferred stock dividends   (627)          
Basic and diluted loss per share:               
Loss available to common stockholders
  $(6,198)   73,603   $(0.08)

 

There were an additional aggregate potentially dilutive weighted-average shares of 981,000 from convertible securities outstanding for the three and six months ended June 30, 2024 and June 30, 2023. These securities were not considered in calculating diluted net income (loss) per share for the three and six months ended June 30, 2024 and the six months ended June 30, 2023, as their effect would have been anti-dilutive.